U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C26H20FN5O2S2
Molecular Weight 517.598
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of N-(3-FLUORO-4-(2-(1-METHYL-1H-IMIDAZOL-4-YL)THIENO(3,2-B)PYRIDIN-7-YLOXY)PHENYLCARBAMOTHIOYL)-2-PHENYLACETAMIDE

SMILES

CN1C=NC(=C1)C2=CC3=NC=CC(OC4=C(F)C=C(NC(=S)NC(=O)CC5=CC=CC=C5)C=C4)=C3S2

InChI

InChIKey=UFICVEHDQUKCEA-UHFFFAOYSA-N
InChI=1S/C26H20FN5O2S2/c1-32-14-20(29-15-32)23-13-19-25(36-23)22(9-10-28-19)34-21-8-7-17(12-18(21)27)30-26(35)31-24(33)11-16-5-3-2-4-6-16/h2-10,12-15H,11H2,1H3,(H2,30,31,33,35)

HIDE SMILES / InChI

Molecular Formula C26H20FN5O2S2
Molecular Weight 517.598
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Approval Year

Targets

Targets

Primary TargetPharmacologyConditionPotency
0.026 µM [IC50]
Target ID: P08581
Gene ID: 4233.0
Gene Symbol: MET
Target Organism: Homo sapiens (Human)
0.037 µM [IC50]
PubMed

PubMed

TitleDatePubMed
N-(3-fluoro-4-(2-arylthieno[3,2-b]pyridin-7-yloxy)phenyl)-2-oxo-3-phenylimidazolidine-1-carboxamides: a novel series of dual c-Met/VEGFR2 receptor tyrosine kinase inhibitors.
2009 Mar 1
Patents
Substance Class Chemical
Created
by admin
on Sat Dec 16 09:49:49 GMT 2023
Edited
by admin
on Sat Dec 16 09:49:49 GMT 2023
Record UNII
93M6577H9D
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
N-(3-FLUORO-4-(2-(1-METHYL-1H-IMIDAZOL-4-YL)THIENO(3,2-B)PYRIDIN-7-YLOXY)PHENYLCARBAMOTHIOYL)-2-PHENYLACETAMIDE
Systematic Name English
BENZENEACETAMIDE, N-(((3-FLUORO-4-((2-(1-METHYL-1H-IMIDAZOL-4-YL)THIENO(3,2-B)PYRIDIN-7-YL)OXY)PHENYL)AMINO)THIOXOMETHYL)-
Systematic Name English
Code System Code Type Description
PUBCHEM
24901704
Created by admin on Sat Dec 16 09:49:49 GMT 2023 , Edited by admin on Sat Dec 16 09:49:49 GMT 2023
PRIMARY
EPA CompTox
DTXSID60647874
Created by admin on Sat Dec 16 09:49:49 GMT 2023 , Edited by admin on Sat Dec 16 09:49:49 GMT 2023
PRIMARY
CAS
875337-44-3
Created by admin on Sat Dec 16 09:49:49 GMT 2023 , Edited by admin on Sat Dec 16 09:49:49 GMT 2023
PRIMARY
FDA UNII
93M6577H9D
Created by admin on Sat Dec 16 09:49:49 GMT 2023 , Edited by admin on Sat Dec 16 09:49:49 GMT 2023
PRIMARY